Jump to content

Rayne Rouce

From Wikipedia, the free encyclopedia
(Redirected from Draft:Rayne Rouce)

Rayne Rouce is an American pediatric hematologist-oncologist, physician scientist, and community leader who has authored over 200 original songs.[1]

Early life and education

[edit]

Rouce attended Xavier University of Louisiana, a historically black college and university (HBCU) that has matriculated a record number of Black aspiring physicians to medical school.[2] Rouce earned her medical degree and completed her residency in Pediatrics at the University of Texas Medical Branch in Galveston. She completed her fellowship in pediatric hematology/oncology at Texas Children's Cancer Center.[3]

Career

[edit]

Rouce is Associate Professor of Pediatrics[4] at Baylor College of Medicine, where she leads the task force for promoting equity in cancer trials. She leads DEI programs for several scientific organizations.[5] Rouce serves on the Board of Directors of the Leukemia & Lymphoma Society[5] and National Marrow Donor Program.[6] She directs research on CAR T cell therapy and stem cell transplantation.[7]

Community engagement

[edit]

Rouce leads a weekend science program at Baylor.[1] She spent years volunteering for the Periwinkle Foundation helping children, siblings, and families affected with cancer. She served on a medical mission to Bolivia.[3] Her fluency in Spanish has helped her serve patients and their families in Texas.[8] She advocates for dismantling barriers to access to transplantation and other cell therapies.[9]

After experiencing Hurricane Katrina while in college and losing her possessions during Hurricane Ike as a medical student in Galveston, Texas, Rouce organized relief efforts during both Hurricane Harvey and Hurricane Maria.[10]

Educational songs

[edit]

Rouce raps her own educational songs as "Rizzo".[1] She has performed her original science rap songs at national meetings, including the American Society of Hematology's ASH-a-Palooza each year since 2018. Her 2020 video performance, which can be viewed online,[1] is accompanied by the ASH Blood Drop mascot and includes the lyrics:

What's a sickle cell, what does that entail? A gene, modified, stem cell? A congressional briefing with a strategic plan? Can we do it in this lifetime? Yes we can! The sky's the limit, benign or malignant!

In the song, she correctly predicted the development of gene therapy for sickle cell disease, namely Casgevy, which was FDA approved in 2023.[11] Her 2024 performance at the HOSA international leadership conference is also viewable online.[12]

Selected publications

[edit]

References

[edit]
  1. ^ a b c d Phifer, Andy (February 3, 2021). "'Swag worthy' doctor splits time between patients, rap music". Baylor College of Medicine. Retrieved September 4, 2024.
  2. ^ "Inspiring Lyrics Help Fight Childhood Cancer". American Society of Hematology. Retrieved September 5, 2024.
  3. ^ a b "Interview With 2016 ASH-AMFDP Recipient Rayne H. Rouce, MD". American Society of Hematology. June 28, 2016. Retrieved September 4, 2024.
  4. ^ "Rayne H. Rouce, MD: Cancer and Blood Disorders". Texas Children's Hospital. Retrieved September 5, 2024.
  5. ^ a b "The Leukemia & Lymphoma Society Welcomes Five Members to its Board of Directors". Leukemia & Lymphoma Society. July 1, 2024. Retrieved September 5, 2024.
  6. ^ "Board of Directors: Rayne Rouce, MD". NMDP. Retrieved September 8, 2024.
  7. ^ Scott, Ryan (September 4, 2024). "Tisagenlecleucel Climbs into Earlier Lines of Therapy for Pediatric R/R B-ALL". Onc Live. Retrieved September 5, 2024.
  8. ^ ""New Frontiers of Cancer Cell and Gene Therapy: Is the Future Now?"". NIH VideoCast CCR Grand Rounds. NIH. May 17, 2024. Retrieved September 5, 2024.
  9. ^ Rouce, Rayne (January 31, 2023). "BLOG: Creating systemic change with the ASTCT-NMDP ACCESS Initiative". Healio. Retrieved September 5, 2024.
  10. ^ Bagley, Allison (May 10, 2018). "Physician Rayne Rouce activated social network to rescue families, gather donations". Houston Chronicle. Retrieved September 4, 2024.
  11. ^ "Vertex and CRISPR Therapeutics Announce US FDA Approval of Casgevy (exagamglogene autotemcel) for the Treatment of Sickle Cell Disease" (Press release). Vertex Pharmaceuticals. December 8, 2023. Archived from the original on December 9, 2023. Retrieved September 21, 2024 – via Business Wire.
  12. ^ Kigera, Noni (July 23, 2024). "HOSA Alumna Dr. Rayne Rouce Engages and Inspires with Her Science Rap at the 2024 ILC". HOSA Future Health Professionals. Retrieved September 5, 2024.